Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity

European Urology

Volumn 64, Issue 6, 2013, Pages 931-938

  Ghadjar, Pirus ^a   Jackson, Andrew ^a   Spratt, Daniel E ^a   Oh, Jung Hun ^a   Munck Af Rosenschöld, Per ^a   Kollmeier, Marisa ^a   Yorke, Ellen ^a   Hunt, Margie ^a   Deasy, Joseph O ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Prostatic neoplasms; Radiotherapy; Toxicity; Urogenital abnormalities

Indexed keywords

ADJUVANT THERAPY; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; DYSURIA; FOLLOW UP; HEMATURIA; HUMAN; INCONTINENCE; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; TREATMENT OUTCOME; URINARY URGENCY; URINE RETENTION; UROGENITAL TRACT DISEASE; UROGENITAL TRACT TOXICITY;

PROSTATIC NEOPLASMS; RADIOTHERAPY; TOXICITY; UROGENITAL ABNORMALITIES;

AGED; HUMANS; INCIDENCE; MALE; MALE UROGENITAL DISEASES; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; TIME FACTORS;

EID: 84887405249     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.02.001     Document Type: Article

References (17)

1. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
2. E.A. Platz, C.E. Joshu, A.M. Mondul, S.B. Peskoe, W.C. Willett, and E. Giovannucci Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men J Urol 188 2012 496 501
3. V. Fonteyne, G. Villeirs, N. Lumen, and G. De Meerleer Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer Radiother Oncol 92 2009 42 47
4. S.T. Peeters, W.D. Heemsbergen, and W.L. van Putten Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019 1034
5. A. Karlsdottir, L.P. Muren, T. Wentzel-Larsen, and O. Dahl Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity Int J Radiat Oncol Biol Phys 70 2008 1478 1486
6. L. Budaus, M. Bolla, and A. Bossi Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature Eur Urol 61 2012 112 127
7. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
8. G.A. Viani, L.G. da Silva, and E.J. Stefano High-dose conformal radiotherapy reduces prostate cancer-specific mortality: results of a meta-analysis Int J Radiat Oncol Biol Phys 83 2012 e619 e625
9. V. Beckendorf, S. Guerif, and E. Le Prise 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial Int J Radiat Oncol Biol Phys 80 2011 1056 1063
10. M.J. Zelefsky, Z. Fuks, and M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881
11. E. Basch, A. Iasonos, and T. McDonough Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study Lancet Oncol 7 2006 903 909
12. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557 discussion 1564
13. D.E. Spratt, X. Pei, J. Yamada, M.A. Kollmeier, B. Cox, and M.J. Zelefsky Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer Int J Radiat Oncol Biol Phys 85 2013 686 692
14. M.J. Barry, W.O. Williford, and Y. Chang Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154 1995 1770 1774
15. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
16. L.J. Peters, H.R. Withers, and B.W. Brown Complicating issues in complication reporting Int J Radiat Oncol Biol Phys 31 1995 1349 1351
17. R. Malik, A.B. Jani, and S.L. Liauw External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS) Int J Radiat Oncol Biol Phys 80 2011 1080 1086